Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Article
PubMed
Google Scholar
Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E. DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables. Mol Oncol. 2011;5(1):77–92.
Article
CAS
PubMed
Google Scholar
Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet. 2007;8(4):286–98.
Article
CAS
PubMed
Google Scholar
Kang HJ, Kim JM, Kim SY, Kim SW, Shin IS, Kim HR, Park MH, Shin MG, Yoon JH, Yoon JS. A longitudinal study of BDNF promoter methylation and depression in breast Cancer. Psychiatry Investig. 2015;12(4):523–31.
Article
PubMed
PubMed Central
Google Scholar
Woo HD, Kim J. Global DNA Hypomethylation in peripheral blood leukocytes as a biomarker for Cancer risk: a meta-analysis. PLoS One. 2012;7(4):e34615.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guan Z, Yu H, Cuk K, Zhang Y, Brenner H. Whole-blood DNA methylation markers in early detection of breast Cancer: a systematic literature review. Cancer Epidemiol Biomark Prev. 2019;28(3):496–505.
Article
CAS
Google Scholar
Mžik M, Chmelařová M, John S, Laco J, Slabý O, Kiss I, Bohovicová L, Palička V, Nekvindová J. Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma. Clin Chem Lab Med. 2016;54(12):1971–80.
Article
PubMed
Google Scholar
Bruno P, Gentile G, Mancini R, Vitis CD, Esposito MC, Scozzi D, Mastrangelo M, Ricci A, Mohsen I, Ciliberto G. WT1 CpG islands methylation in human lung cancer: a pilot study. Biochem Biophys Res Commun. 2012;426(3):306–9.
Article
CAS
PubMed
Google Scholar
Laux DE, Curran EM, Welshons WV, Lubahn DB, Huang THM. Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas. Breast Cancer Res Treat. 1999;56(1):35–43.
Article
CAS
PubMed
Google Scholar
Werner H, Re GG, Drummond IA, Sukhatme VP, Rd RF, Sens DA, Garvin AJ, Leroith D, Roberts CT. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci U S A. 1993;90(12):5828–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Paik S. Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res Treat. 1992;22(1):31–8.
Article
CAS
PubMed
Google Scholar
Silberstein GB, Horn KV, Strickland P, Roberts CT, Daniel CW. Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci U S A. 1997;94(15):8132–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nakamura J, Kitajima Y, Kai K, Hashiguchi K, Hiraki M, Noshiro H, Miyazaki K. Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric Cancer. Am J Pathol. 2011;178(2):515.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol. 2001;158(3):905–19.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sung HY, Ju W, Ahn JH. DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induces an aggressive phenotype in ovarian cancer cells. Yonsei Med J. 2014;55(6):1656–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wojdacz TK, Windeløv JA, Thestrup BB, Damsgaard TE, Overgaard J, Hansen LL. Identification and characterization of locus-specific methylation patterns within novel loci undergoing hypermethylation during breast cancer pathogenesis. Breast Cancer Res. 2014;16(1):R17.
Article
PubMed
PubMed Central
Google Scholar
Shu XO, Yang G, Jin F, Liu D, Kushi L, Wen W, Gao YT, Zheng W. Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women's health study. Eur J Clin Nutr. 2004;58(1):17–23.
Article
CAS
PubMed
Google Scholar
Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, et al. European prospective investigation into Cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113–24.
Article
CAS
PubMed
Google Scholar
Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thurlimann B, Senn HJ, Panel M. Tailoring therapies--improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast Cancer 2015. Ann Oncol. 2015;26(8):1533–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Conway K, Edmiston SN, May R, Pei FK, Chu H, Bryant C, Tse CK, Swift-Scanlan T, Geradts J, Troester MA. DNA methylation profiling in the Carolina breast Cancer study defines cancer subclasses differing in clinicopathologic characteristics and survival. Breast Cancer Res Bcr. 2014;16(5):450.
Article
PubMed
Google Scholar
Holm K, Hegardt C, Staaf J, Vallonchristersson J, Jönsson G, Olsson H, Borg Å, Ringnér M. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns. Breast Cancer Res. 2010;12(3):R36.
Article
PubMed
PubMed Central
Google Scholar
Koestler DC, Marsit CJ, Christensen BC, Accomando W, Langevin SM, Houseman EA, Nelson HH, Karagas MR, Wiencke JK, Kelsey KT. Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers. Cancer Epidemiol Biomark Prev. 2012;21(8):1293–302.
Article
CAS
Google Scholar
Wang Y, Li D, Li X, Teng C, Zhu L, Cui B, Zhao Y, Hu F. Prognostic significance of hMLH1/hMSH2 gene mutations and hMLH1 promoter methylation in sporadic colorectal cancer. Med Oncol. 2014;31(7):39.
Article
PubMed
Google Scholar
Gupta S, Jaworska-Bieniek K, Narod SA, Lubinski J, Wojdacz TK, Jakubowska A. Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer. Breast Cancer Res Treat. 2014;148(3):615–22.
Article
CAS
PubMed
Google Scholar
Chung W, Bondaruk J, Jelinek J, Lotan Y, Liang S, Czerniak B, Issa JP. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1483.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gao HL, Wang X, Sun HR, Zhou JD, Lin SQ, Xing YH, Zhu L, Zhou HB, Zhao YS, Chi Q. Methylation status of transcriptional modulatory genes associated with colorectal cancer in Northeast China. Gut Liver. 2018;12(2)..
Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic acids research. 2007;35(6):e41.
Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol. 1977;105(5):488–95.
Article
CAS
PubMed
Google Scholar